Back to EW

Edwards Lifesciences Corp Proceeds from Stock Issuance 2015-2025 | EW

Beta

What is Edwards Lifesciences Corp's current proceeds from stock issuance?

Edwards Lifesciences Corp (EW) annual proceeds from stock issuance for 2025 was $89.2M, a 1.55% decline from 2024.

What was Edwards Lifesciences Corp's proceeds from stock issuance in 2024?

Edwards Lifesciences Corp annual proceeds from stock issuance for 2024 was $90.6M, a 8.63% increase from 2023.

What was Edwards Lifesciences Corp's proceeds from stock issuance in 2023?

Edwards Lifesciences Corp annual proceeds from stock issuance for 2023 was $83.4M, a 28.70% increase from 2022.

What is Edwards Lifesciences Corp's 5-year proceeds from stock issuance CAGR?

Edwards Lifesciences Corp proceeds from stock issuance grew at a compound annual growth rate (CAGR) of 2.41% from FY2020 to FY2025, going from $79.2M to $89.2M over 5 years.

Proceeds from Stock Issuance History

Year-over-year comparison from 10-K annual reports

Key Statistics
Trend Direction
Stable
CAGR+2.4%
FY2020
$79.2M
→
FY2025
$89.2M
1516171819202122232425
5 years selected
Proceeds from Stock Issuance History
PeriodValueChangeSource
FY2025$89.2M-1.5%10-K
FY2024$90.6M+8.6%10-K
FY2023$83.4M+28.7%10-K
FY2022$64.8M-21.2%10-K
FY2021$82.2M+3.8%10-K
FY2020$79.2M-28.3%10-K
FY2019$110.4M+6.5%10-K
FY2018$103.7M+33.6%10-K
FY2017$77.6M+6.2%10-K
FY2016$73.1M+14.9%10-K
FY2015$63.6M-10-K
Company: Edwards Lifesciences CorpTicker: EWSector: OtherIndustry: Orthopedic, Prosthetic & Surgical Appliances & SuppliesView company profile →